GCM
VAXX

Ghisallo Capital Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Ghisallo Capital Management’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$198K – 165
2022
Q3 		$198K Hold
100,000
– – 0.03% 242
2022
Q2 		$157K Buy
+100,000
New +$378K 0.02% 271

Other funds holding VAXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ghisallo Capital Management's VAXX Position: Q4 2022 in Review

Ghisallo Capital Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2022, closing a stake of 100,000 shares — an estimated $198K sold.

Ghisallo Capital Management first reported a position in VAXX in Q2 2022 and held it in 2 quarters. The position peaked at $198K in Q3 2022. 30 funds tracked by Wall St. Rank hold VAXX as of Q4 2022.

  • Ghisallo Capital Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ghisallo Capital Management sold 100,000 Vaxxinity, Inc. Class A Common Stock shares in Q4 2022, an estimated $198K.
  • Ghisallo Capital Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Ghisallo Capital Management's Vaxxinity, Inc. Class A Common Stock position peaked at $198K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2022.

Based on Ghisallo Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.